The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Nanotechnology applied to overcome tumor drug resistance
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
Gupta, A. K., & Gupta, M. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.10.012 · Cited by 6,771
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Targeting multidrug resistance in cancer
Szakács, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., & Gottesman, M. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1984 · Cited by 3,609
Fang, J., Nakamura, H., & Maeda, H. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.04.009 · Cited by 3,559
Mechanisms of Cancer Drug Resistance
Gottesman, M. M. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103929 · Cited by 2,643
Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438
Hydrogel nanoparticles in drug delivery
Hamidi, M., Azadi, A., & Rafiei, P. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.08.002 · Cited by 2,067
Tumor delivery of macromolecular drugs based on the EPR effect
Torchilin, V. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.03.011 · Cited by 2,032
Polymer conjugates as anticancer nanomedicines
Duncan, R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1958 · Cited by 1,962
Active targeting schemes for nanoparticle systems in cancer therapeutics
Byrne, J. D., Betancourt, T., & Brannon-Peppas, L. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.08.005 · Cited by 1,731
Openings Between Defective Endothelial Cells Explain Tumor Vessel Leakiness
Hashizume, H., Baluk, P., Morikawa, S., McLean, J. W., Thurston, G., Roberge, S., Jain, R. K., & McDonald, D. M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65006-7 · Cited by 1,689
Batrakova, E. V., & Kabanov, A. V. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.04.013 · Cited by 1,278
Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect
Maeda, H., Bharate, G. Y., & Daruwalla, J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.11.010 · Cited by 1,168
Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors.
Gabizon, A., & Papahadjopoulos, D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6949 · Cited by 1,131
Chen, J., Wang, D., Xi, J., Au, L., Siekkinen, A., Warsen, A., Li, Z.-Y., Zhang, H., Xia, Y., & Li, X. (2007) · Nano Letters · doi:10.1021/nl070345g · Cited by 1,025
Yuan, F., Leunig, M., Huang, S. K., Berk, D. A., Papahadjopoulos, D., & Jain, R. K. (1994) · PubMed · Cited by 908
Meng, H., Liong, M., Xia, T., Li, Z., Ji, Z., Zink, J. I., & Nel, A. E. (2010) · ACS Nano · doi:10.1021/nn100690m · Cited by 902
Advances in polymeric micelles for drug delivery and tumor targeting
Kedar, U., Phutane, P., Shidhaye, S., & Kadam, V. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2010.05.005 · Cited by 791
Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
Park, J. W., Hong, K., Kirpotin, D. B., Colbern, G. T., Shalaby, R., Baselga, J. M., Shao, Y. Y., Nielsen, U. B., Marks, J. D., Moore, D. H., et al. (2002) · Clinical Cancer Research · Cited by 766
Design considerations for tumour-targeted nanoparticles
Choi, H. S., Liu, W., Liu, F., Nasr, K., Misra, P., Bawendi, M. G., & Frangioni, J. V. (2010) · Nature Nanotechnology · doi:10.1038/nnano.2009.314 · Cited by 754
Mechanisms of Drug Resistance in Cancer Chemotherapy
Luqmani, Y. A. (2005) · Medical Principles and Practice · doi:10.1159/000086183 · Cited by 651
Stealth Me. PEG‐PLA Nanoparticles Avoid Uptake by the Mononuclear Phagocytes System
Bazile, D., Prud'homme, C., Bassoullet, M., Marlard, M., Spenlehauer, G., & Veillard, M. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600840420 · Cited by 635
Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor
Lee, E. S., Na, K., & Bae, Y. H. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.12.018 · Cited by 577
Extracellular pH distribution in human tumours
Engin, K., Leeper, D. B., Cater, J. R., Thistlethwaite, A. J., Tupchong, L., & McFarlane, J. D. (1995) · International Journal of Hyperthermia · doi:10.3109/02656739509022457 · Cited by 530
Zhao, M., Yang, M., Li, X.-M., Jiang, P., Baranov, E., Li, S., Xu, M., Penman, S., & Hoffman, R. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408422102 · Cited by 484
Drug transport to brain with targeted nanoparticles
Olivier, J.-C. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.108 · Cited by 444
Lee, E. S., Gao, Z., Kim, D., Park, K., Kwon, I. C., & Bae, Y. H. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.04.024 · Cited by 400
Self-citationMulticellular resistance: a paradigm for clinical resistance?
Desoize, B. (2000) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(00)00086-x · Cited by 400
He, Q., Gao, Y., Zhang, L., Zhang, Z., Gao, F., Ji, X., Li, Y., & Shi, J. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.06.066 · Cited by 392
Self-citationResistance mechanisms associated with altered intracellular distribution of anticancer agents
Larsen, A. K., Escargueil, A. E., & Skladanowski, A. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00073-x · Cited by 369
Zhang, W., Shi, Y., Chen, Y., Ye, J., Sha, X., & Fang, X. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.12.039 · Cited by 368
Monsky, W. L., Fukumura, D., Gohongi, T., Ancukiewcz, M., Weich, H. A., Torchilin, V. P., Yuan, F., & Jain, R. K. (1999) · PubMed · Cited by 368
Co-Delivery of siRNA and An Anticancer Drug for Treatment of Multidrug-Resistant Cancer
Saad, M., Garbuzenko, O. B., & Minko, T. (2008) · Nanomedicine · doi:10.2217/17435889.3.6.761 · Cited by 367
Does a targeting ligand influence nanoparticle tumor localization or uptake?
Pirollo, K. F., & Chang, E. H. (2008) · Trends in Biotechnology · doi:10.1016/j.tibtech.2008.06.007 · Cited by 347
Patil, Y., Sadhukha, T., Ma, L., & Panyam, J. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.01.021 · Cited by 317
Panyam, J., Sahoo, S. K., Prabha, S., Bargar, T., & Labhasetwar, V. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00295-3 · Cited by 308
Patil, Y. B., Swaminathan, S. K., Sadhukha, T., Ma, L., & Panyam, J. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.048 · Cited by 304
Cho, H.-J., Yoon, H. Y., Koo, H., Ko, S.-H., Shim, J.-S., Lee, J.-H., Kim, K., Chan Kwon, I., & Kim, D.-D. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.06.028 · Cited by 304
Poly[N-(2-hydroxypropyl)methacrylamide]—I. Radical polymerization and copolymerization
Kopeček, J., & Baẑilová, H. (1973) · European Polymer Journal · doi:10.1016/0014-3057(73)90063-3 · Cited by 300
Doxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer in vitro
Kievit, F. M., Wang, F. Y., Fang, C., Mok, H., Wang, K., Silber, J. R., Ellenbogen, R. G., & Zhang, M. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.01.024 · Cited by 289
Li, S.-D., & Huang, L. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060039w · Cited by 282
MacDiarmid, J. A., Amaro-Mugridge, N. B., Madrid-Weiss, J., Sedliarou, I., Wetzel, S., Kochar, K., Brahmbhatt, V. N., Phillips, L., Pattison, S. T., Petti, C., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1547 · Cited by 272
Shen, F., Chu, S., Bence, A. K., Bailey, B., Xue, X., Erickson, P. A., Montrose, M. H., Beck, W. T., & Erickson, L. C. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.127704 · Cited by 263
Development of HPMA copolymer–anticancer conjugates: Clinical experience and lessons learnt
Duncan, R. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.05.007 · Cited by 252
Li, R., Wu, R., Zhao, L., Wu, M., Yang, L., & Zou, H. (2010) · ACS Nano · doi:10.1021/nn9011225 · Cited by 245
Minko, T., Kopečková, P., Pozharov, V., & Kopeček, J. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00009-1 · Cited by 243
Selective targeting of antibody-conjugated nanoparticles to leukemic cells and primary T-lymphocytes
Dinauer, N., Balthasar, S., Weber, C., Kreuter, J., Langer, K., & von Briesen, H. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.02.038 · Cited by 234
An anticancer drug delivery system based on surfactant-templated mesoporous silica nanoparticles
He, Q., Shi, J., Chen, F., Zhu, M., & Zhang, L. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.015 · Cited by 229
Self-citationQaddoumi, M. G., Ueda, H., Yang, J., Davda, J., Labhasetwar, V., & Lee, V. H. L. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000022411.47059.76 · Cited by 229
Guo, D., Wu, C., Jiang, H., Li, Q., Wang, X., & Chen, B. (2008) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/j.jphotobiol.2008.07.009 · Cited by 218
Wang, X.-X., Li, Y.-B., Yao, H.-J., Ju, R.-J., Zhang, Y., Li, R.-J., Yu, Y., Zhang, L., & Lu, W.-L. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.04.029 · Cited by 216
Self-citationWu, J. H., Lu, Y., Lee, A., Pan, X., Yang, X., Zhao, X. B., & Lee, R. J. (2007) · PubMed · Cited by 216
Wu, A. M., Yazaki, P. J., Tsai, S.-W., Nguyen, K., Anderson, A.-L., McCarthy, D. W., Welch, M. J., Shively, J. E., Williams, L. E., Raubitschek, A. A., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150228297 · Cited by 214
Marin, A., Sun, H., Husseini, G. A., Pitt, W. G., Christensen, D. A., & Rapoport, N. Y. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00262-6 · Cited by 213
Song, X. R., Cai, Z., Zheng, Y., He, G., Cui, F. Y., Gong, D. Q., Hou, S. X., Xiong, S. J., Lei, X. J., & Wei, Y. Q. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.02.018 · Cited by 211
Mechanisms of Multidrug Resistance in Cancer Treatment
Harris, A. L., & Hochhauser, D. (1992) · Acta Oncologica · doi:10.3109/02841869209088904 · Cited by 207
Wang, C.-H., Chiou, S.-H., Chou, C.-P., Chen, Y.-C., Huang, Y.-J., & Peng, C.-A. (2011) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2010.06.010 · Cited by 194
Xiong, X.-B., Ma, Z., Lai, R., & Lavasanifar, A. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.080 · Cited by 193
Kono, K., Kojima, C., Hayashi, N., Nishisaka, E., Kiura, K., Watarai, S., & Harada, A. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.12.017 · Cited by 192
Pegnology: a review of PEG-ylated systems.
Bhadra, D., Bhadra, S., Jain, P., & Jain, N. K. (2002) · PubMed · Cited by 183
Julyan, P. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00124-2 · Cited by 180
Multi-functional nanocarriers for targeted delivery of drugs and genes
Jabr-Milane, L., van Vlerken, L., Devalapally, H., Shenoy, D., Komareddy, S., Bhavsar, M., & Amiji, M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.04.016 · Cited by 171
Gold-doxorubicin nanoconjugates for overcoming multidrug resistance
Gu, Y.-J., Cheng, J., Man, C. W.-Y., Wong, W.-T., & Cheng, S. H. (2012) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.06.005 · Cited by 171
The medicinal chemistry of multidrug resistance (MDR) reversing drugs
Teodori, E., Dei, S., Scapecchi, S., & Gualtieri, F. (2002) · Il Farmaco · doi:10.1016/s0014-827x(02)01229-6 · Cited by 164
Linnet, K., & Ejsing, T. B. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.06.003 · Cited by 163
Targeting tumor angiogenic vasculature using polymer–RGD conjugates
Mitra, A., Mulholland, J., Nan, A., McNeill, E., Ghandehari, H., & Line, B. R. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.09.023 · Cited by 162
Batrakova, E. V., Li, S., Brynskikh, A. M., Sharma, A. K., Li, Y., Boska, M. D., Gong, N., Mosley, R. L., Alakhov, V. Y., Gendelman, H. E., et al. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.004 · Cited by 159
Combined cancer therapy by micellar-encapsulated drug and ultrasound
Rapoport, N. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.09.048 · Cited by 159
Yadav, S. K., van Vlerken, L. E., Little, S. R., & Amiji, M. M. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0790-y · Cited by 152
Emerging nanomaterials for targeting subcellular organelles
Huang, J. G., Leshuk, T. M. C., & Gu, F. (2011) · Nano Today · doi:10.1016/j.nantod.2011.08.002 · Cited by 150
Jiang, J., Yang, S.-J., Wang, J., Yang, L., Xu, Z.-Z., Yang, T., Liu, X.-Y., & Zhang, Q. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.06.011 · Cited by 149
Pakunlu, R. I., Wang, Y., Tsao, W., Pozharov, V. P., Cook, T. J., & Minko, T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0001 · Cited by 148
Zhang, Y., Tang, L., Sun, L., Bao, J., Song, C. X., Huang, L., Liu, K., Tian, Y., Tian, G., Li, Z., et al. (2009) · Acta Biomaterialia · doi:10.1016/j.actbio.2009.11.035 · Cited by 134
Pakunlu, R. I., Wang, Y., Saad, M., Khandare, J. J., Starovoytov, V., & Minko, T. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.06.010 · Cited by 134
Multidrug Resistance in Cancer
Baguley, B. C. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-416-6_1 · Cited by 133
Milane, L. S., Ganesh, S., Shah, S., Duan, Z., & Amiji, M. M. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.03.032 · Cited by 128
Liu, C., Zhao, G., Liu, J., Ma, N., Chivukula, P., Perelman, L. A., Okada, K., Chen, Z., Gough, D., & Yu, L. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.08.013 · Cited by 127
Vergara, D., Bellomo, C., Zhang, X., Vergaro, V., Tinelli, A., Lorusso, V., Rinaldi, R., LVOV, Y. M., Leporatti, S., & Maffia, M. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.10.014 · Cited by 124
Reversal of doxorubicin-resistance by multifunctional nanoparticles in MCF-7/ADR cells
Shieh, M., Hsu, C., Huang, L.-Y., Chen, H., Huang, F., & Lai, P. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.03.017 · Cited by 122
Lukianova‐Hleb, E. Y., Belyanin, A., Kashinath, S., Wu, X., & Lapotko, D. O. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.015 · Cited by 121
Devalapally, H., Duan, Z., Seiden, M. V., & Amiji, M. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4973 · Cited by 121
Xu, H., Wang, K. Q., Deng, Y. H., & Chen, D. W. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.02.049 · Cited by 120
Milane, L. S., Duan, Z., & Amiji, M. M. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2010.12.009 · Cited by 119
Febvay, S., Marini, D. M., Belcher, A. M., & Clapham, D. E. (2010) · Nano Letters · doi:10.1021/nl101157z · Cited by 117
Chen, R., Khormaee, S., Eccleston, M., & Slater, N. K. H. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.12.036 · Cited by 108
Sprincl, L., Exner, J., Stĕrba, O., & Kopeček, J. (1976) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820100612 · Cited by 107
Preparation of hemoglobin-loaded nano-sized particles with porous structure as oxygen carriers
Zhao, J. F., Liu, C., Yuan, Y., Tao, X., Shan, X.-Q., Sheng, Y., & Wu, F. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.10.012 · Cited by 104
Tumor selectivity of stealth multi-functionalized superparamagnetic iron oxide nanoparticles
Fan, C., Gao, W., Chen, Z., et al. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.10.038 · Cited by 104
Degradable Poly(β-amino ester) nanoparticles for cancer cytoplasmic drug delivery
Shen, Y., Tang, H., Zhan, Y., Kirk, E. A. V., & Murdoch, W. J. (2009) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2008.09.003 · Cited by 102
Yu, Y., Wang, Z., Zhang, L., Yao, H.-J., Zhang, Y., Li, R., Ju, R.-J., Wang, X., Zhou, J., Li, N., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.10.085 · Cited by 100
Self-citationHubensack, M., Müller, C., Höcherl, P., Fellner, S., Spruß, T., Bernhardt, G., & Buschauer, A. (2007) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-007-0323-9 · Cited by 97
Minko, T., Kopečková, P., & Kopec̆ek, J. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00186-2 · Cited by 97
Li, C. J., Miyamoto, Y., Kojima, Y., & Maeda, H. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.179 · Cited by 96
Minicells: Versatile vectors for targeted drug or si/shRNA cancer therapy
MacDiarmid, J. A., & Brahmbhatt, H. N. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2011.04.008 · Cited by 94
Segal, E., Pan, H., Benayoun, L., Kopečková, P., Shaked, Y., Kopeček, J., & Satchi‐Fainaro, R. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.02.059 · Cited by 92
Hua, M., Yang, H., Liu, H.-L., Tsai, R., Pang, S., Chuang, K., Chang, Y., Hwang, T., Chang, Y., Chuang, H., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.08.014 · Cited by 85
Boomer, J. A., Qualls, M. M., Inerowicz, H. D., Haynes, R. H., Patri, V. S., Kim, J.-M., & Thompson, D. H. (2008) · Bioconjugate Chemistry · doi:10.1021/bc800239b · Cited by 84
Johnson, R. N., Chu, D. S. H., Shi, J., Schellinger, J. G., Carlson, P. M., & Pun, S. H. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.009 · Cited by 79
Zalipsky, S., Saad, M., Kiwan, R., Ber, E., Yu, N. Y., & Minko, T. (2007) · Journal of drug targeting · doi:10.1080/10611860701499946 · Cited by 77
Xu, Z., Zhang, Z., Chen, Y., Chen, L., Lin, L., & Li, Y. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.103 · Cited by 76
Yang, Y., Zhou, Z., He, S., Fan, T., Jin, Y., Zhu, X. D., Chen, C., Zhang, Z., & Huang, Y. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.12.007 · Cited by 65
Overcoming cellular multidrug resistance using classical nanomedicine formulations
Kunjachan, S., Błauż, A., Möckel, D., Theek, B., Kiessling, F. M., Etrych, T., Ulbrich, K., van Bloois, L., Storm, G., Bartosz, G., et al. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.08.028 · Cited by 64
Wang, J., Tao, X., Zhang, Y., Wei, D., & Ren, Y. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.02.007 · Cited by 64
Star-shaped immunoglobulin-containing HPMA-based conjugates with doxorubicin for cancer therapy
Etrych, T., Mrkvan, T., Říhová, B., & Ulbrich, K. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.06.007 · Cited by 63
Regulation of endocytic processes by pH
Yamashiro, D. J., & Maxfield, F. R. (1988) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(88)90078-8 · Cited by 58
Ji, X., Gao, Y., Chen, L., Zhang, Z., Deng, Y., & Li, Y. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.10.003 · Cited by 52
Siwak, D. R., Tari, A. M., & Lopez‐Berestein, G. (2002) · PubMed · Cited by 46
Howard, B., Gao, Z., Lee, S.-W., Seo, M.-H., & Rapoport, N. Y. (2006) · American Journal of Drug Delivery · doi:10.2165/00137696-200604020-00005 · Cited by 41
Self-citationGreish, K. F., Ray, A., Bauer, H., Larson, N., Malugin, A., Pike, D. B., Haider, M. A., & Ghandehari, H. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.12.015 · Cited by 40
Designing PEGylated therapeutic molecules: advantages in ADMET properties
Hamidi, M., Rafiei, P., & Azadi, A. (2008) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.3.11.1293 · Cited by 36
Debotton, N., Parnes, M., Kadouche, J., & Benita, S. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.01.014 · Cited by 35
Tumor-targeting amino acid auxotrophic Salmonella typhimurium
Hoffman, R. M. (2009) · Amino Acids · doi:10.1007/s00726-009-0261-8 · Cited by 31
Tijerina, M., Fowers, K. D., Kopečková, P., & Kopec̆ek, J. (2000) · Biomaterials · doi:10.1016/s0142-9612(00)00161-7 · Cited by 29
Galmarini, C. M., Warren, G., Senanayake, M. T., & Vinogradov, S. V. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.05.028 · Cited by 28
Overcoming MDR by Ultrasound-Induced Hyperthermia and P-Glycoprotein Modulation
Yang, L., Lillehei, K. O., Cobb, W. N., Christians, U., & Ng, K. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5938 · Cited by 21
Targeting P-glycoprotein for Effective Oral Anti-Cancer Chemotherapeutics
Bebawy, M., & Sze, D. (2008) · Current Cancer Drug Targets · doi:10.2174/156800908783497168 · Cited by 20
Griffiths, P. C., Paul, A., Apostolovic, B., Klok, H., Luca, E. D., King, S. M., & Heenan, R. K. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.03.030 · Cited by 16
THE POTENTIAL OF DRUG-CARRYING IMMUNOLIPOSOMES AS ANTICANCER AGENTS
Russian, N. N. B., & Rams, M. (2008) · CyberLeninK (CyberLeninka) · Cited by 13
Zhu, Q., Liu, W., Guo, L., et al. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.068 · Cited by 9
Nagamitsu, A., Inuzuka, T., Greish, K. F., & Maeda, H. (2007) · Drug Delivery System · doi:10.2745/dds.22.510 · Cited by 6
Cited by
Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: A review
Kanamala, M., Wilson, W. R., Yang, M., Palmer, B. D., & Wu, Z. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.01.061 · Cited by 1,004
Emran, T. B., Shahriar, A., Mahmud, A. R., Rahman, T., Abir, M. H., Siddiquee, M. F. R., Ahmed, H., Rahman, N., Nainu, F., Wahyudin, E., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.891652 · Cited by 606
Kemp, J. A., Shim, M. S., Heo, C. Y., & Kwon, Y. J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.019 · Cited by 506
Sandwich-type immunosensors and immunoassays exploiting nanostructure labels: A review
Pei, X., Zhang, B., Tang, J., Liu, B., Lai, W., & Tang, D. (2013) · Analytica Chimica Acta · doi:10.1016/j.aca.2012.10.060 · Cited by 454
Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status
van der Meel, R., Vehmeijer, L. J. C., Kok, R. J., Storm, G., & van Gaal, E. V. B. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.08.012 · Cited by 398
Metadata
- Authors
- Gao, Z., Zhang, L., & Sun, Y.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2012-08
- Volume
- 162
- Issue
- 1
- Pages
- 45-55
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2029071448
- Cited by
- 303
- References
- 122
- FWCI
- 9.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.